Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Indraprastha Medical Corporation Limited (NSE: INDRAMEDCO), ISIN INE681B01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INDRAMEDCO last traded at ₹331.70 (-1.65%), with a 52-week range of ₹293.65 to ₹623.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 51.00%, FIIs 2.39%, DIIs 1.77%, mutual funds 0.91%.
EquiSense Score (ECS): 48/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.